Christopher G. Hayes, Chief Legal Officer at Verrica Pharmaceuticals Inc. (VRCA), bought 2,500 shares at $9.79 ($24K) on 2021-06-04, disclosed to the SEC on 2021-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRCA | SELL | 2024-07-23 | $306K | — | Filing → |
| VRCA | SELL | 2023-11-16 | $164K | — | Filing → |
| VRCA | SELL | 2023-07-25 | $326K | — | Filing → |